| back to CDH1 products | |
| This is a review about E-cadherin antibodies, based on 37 published articles using E-cadherin antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited E-cadherin antibody. Information in this review (with links to publications) can be searched freely. |
| list by method:
blocking or activating expriments,
ELISA,
flow cytometry,
immunocytochemistry,
immunohistochemistry,
immunoprecipitation,
western blot |
SIGMA search SIGMA CDH1 products
Other Brands or Spellings: SIGMA-ALDRICH, SIGMA CHEMICAL, SIGMA CHEMICAL COMPANY, SIGMA-ALDRICH FINE CHEMICALS |
|
In 2003, Michael H Roh et al. used Sigma-Aldrich rat monoclonal anti-uvomorulin/E-cadherin in immunostaining as a marker of adherens junctions to study the CRB3 overexpression during the biogenesis of tight junctions and adherens junctions. In 2005, Thorsten Maretzky et al. used Sigma N-terminal E-cadherin antibody DECMA-1 in blocking expriments to study the regulation of E-cadherin shedding and beta-catenin translocation by ADAM10.
|
TRANSDUCTION LABORATORIES
Other Brands or Spellings: BD BIOSCIENCES, BD, BD BIOSCIENCES CLONTECH, BD BIOSCIENCES PHARMINGEN, BD TRANSDUCTION LABORATORIES, BD TRANSDUCTION LABORATORY, PHARMINGEN, PHARMINOGEN, BD PHARMINGEN, BECTON DICKINSON, TRANSDUCTION LABORATORY, BECTON DICKINSON TRANSDUCTION LABORATORIES, BD TRANSDUCTION |
Immunocytochemistry In 2001, A Suzuki et al. used Transduction Laboratories mouse anti E-cadherin monoclonal antibody to study the critical role for atypical protein kinase C in establishing epithelia-specific junctional structures by mediating the formation of the evolutionarily conserved PAR protein complex. In 2003, Carol Wadham et al. used Transduction Laboratories anti-E-cadherin monoclonal antibody to study the protein tyrosine phosphatase Pez as a major phosphatase of adherens junctions to dephosphorylates beta-catenin, and Victoria P Ramsauer et al. used BD Biosciences monoclonal E-cadherin antibodies (clone 34 and 36) to study ErbB2 translocation in polarized epithelial cells.
Immunohistochemistry
2001 C Graltzinger et al. used Transduction Laboratories monoclonal anti-E-cadherin antibody to study expression of LI-cadherin in intestinal metaplasia and in gastric cancer. In 2002, Ya Chung Tian et al. used Transduction Laboratories mouse monoclonal antibody against human E-cadherin to examine the influence of transforming growth factor (TGF)-ß1 on proximal tubular epithelial cell-cell interaction, with particular emphasis on the regulation of adherens junction complex formation. In 2003, Tsutomu Imai et al. used Transduction Laboratories monoclonal anti-E-cadherin antibody (number 20820, clone 36) to study aberrant expression of E-cadherin in ovarian carcinoma cells. In 2004, Soichi Tsutsumi et al. used PharMingen anti-E-cadherin antibody to study the increased pancreatic cancer metastasis by autocrine motility factor signaling, and Martin Knöfler et al. used C20820 to study the transcriptional regulation of the human chorionic gonadotropin beta gene during villous trophoblast differentiation. In 2005, Nancy Gavert et al. used it to study L1 expression in colon cancers, and Agnieszka K Witkiewicz et al. to study the association of beta-Methylacyl-CoA racemase protein expression with the degree of differentiation in breast cancer.
Immunoprecipitation
In 2003, Philippe Marambaud et al. used BD Transduction Laboratories anti-E-cadherin (C36) antibody to study the effect of PS1 FAD mutations, Josiane Sancacau et al. used (clone 34, mIgG2b) antibody to study the migratory-adhesive switch in Ewing's sarcoma cells triggered by matrix metalloproteinase-9 silencing, and Jonathan Rios-Doria et al. used C20820 to study E-cadherin proteolytic cleavage in prostate and mammary epithelial cells. In 2004, Catherine Hogan et al. used Transduction Laboratories E-cadherin antibody against cytoplasmic portion to study the role of Rap1 cell-cell contact formation.
Western blot
In 2002, Qi Chen et al. used Transduction Laboratories anti-E-cadherin antibody to study a novel mechanism for the regulation of amyloid precursor protein metabolism, and Nathalie Jonca et al. used C20820 to study the adhesive properties of corneodesmosin. In 2003, Jose Piedra et al. used Transduction Laboratories monoclonal antibody against E-cadherin to study the function of p120 catenin-associated Fer and Fyn tyrosine kinases. In 2004, Rachael Z Murray et al. used it to study the role of the deubiquitylating enzyme FAM in the trafficking of beta-catenin and E-cadherin in epithelia. In 2005, Thorsten Maretzky et al. used BD monoclonal antibody against the cytoplasmic domain of E-cadherin (C36) in western blot, immunocytochemistry, and immunoprecipitationto study the regulation of E-cadherin shedding and beta-catenin translocation by ADAM10, Takashi Hoshino et al. used it in western blot and immunocytochemistry to study the regulation of E-cadherin endocytosis by nectin, and David M Bryant et al. to study the effect of E-cadherin on fibroblast growth factor receptor 1. In 2006, Sylvia Major et al. tested BD Transduction E-Cadherin antibody in western blot in the Abminer project.
|
SANTA CRUZ BIOTECHNOLOGY
Other Brands or Spellings: SANTA CRUZ, SANTA CRUZ BIOTECH, SANTA CRUZ BIOTECHNOLOGY INC., SANTA CRUZ BIOTECHNOLOGY INC, SANTZ CRUZ, SANTA CRUZ BIOTECHNOLOGIES |
|
In 2003, Jonathan Rios-Doria et al. used Santa Cruz Biotechnology E-cadherin antibody (SC-1499) in western blot to study E-cadherin proteolytic cleavage in prostate and mammary epithelial cells, Tsutomu Imai et al. used Santa Cruz mouse anti-E-cadherin monoclonal antibody in western blot to study aberrant expression of E-cadherin in ovarian carcinoma cells, Josiane Sancacau et al. used Santa Cruz rabbit polyclonal anti-E-cadherin antibody (H-108) in western blot and immunocytochemistry to study the migratory-adhesive switch in Ewing's sarcoma cells triggered by matrix metalloproteinase-9 silencing. In 2004, Etienne Morel et al. used Santa Cruz rabbit anti-human E-cadherin (HB-108) antibody in immunocytochemistry to study prion protein PrPc expression in human enterocyte cell-cell junctional domainsm and Lillian Ouko et al. used it in immunohistochemistry to study the role of wnt11 signaling in proliferation, transformation, and migration of IEC6 intestinal epithelial cells. In 2005, Olivera Stojadinovic et al. used SCBT E-cadherin antibody in immunohistochemistry and immunocytochemistry to investigate the expression of bet-catenin and c-myc in chronic wounds, and Thorsten Maretzky et al. used SCBT anti-E-cadherin ectodomain antibody (H108) in western blot, immunocytochemistry, and immunoprecipitationto study the regulation of E-cadherin shedding and beta-catenin translocation by ADAM10.
|
ZYMED LABORATORIES
Other Brands or Spellings: INVITROGEN, BIOSOURCE, BIOSOURCE INTERNATIONAL, ZYMED, CALTAG, MOLECULAR PROBES, MEDGENIX DIAGNOSTICS, MEDGENIX, DYNAL ASA, CALTAG LABORATORIES |
|
In 2004, Etienne Morel et al. used Zymed Laboratories mouse HECD1 anti-human E-cadherin monoclonal antibody in western blot and used Zymed Laboratories rat anti-mouse E-cadherin monoclonal antibody (ECCD-2) in immunocytochemistry study prion protein PrPc expression in human enterocyte cell-cell junctional domains, and Catherine Hogan et al. used Zymed E-cadherin antibody (against extracellular portion) in immunocytochemistry to study the role of Rap1 cell-cell contact formation. Maria Malminen et al. used Zymed Laboratories mouse monoclonal E-cadherin (13-1700) antibody in immunohistochemistry to study NF1 expression during the early development of human epidermis in 2002. In 2006, A Persson et al. tested Zymed CDH1 antibody in immunohistochemistry in the HPA (CAB000087) project. Zymed anti-E-cadherin antibody was used in western blot in 2001 by T E Meigs et al. to study the interaction of Galpha12 and Galpha13 with the cytoplasmic domain of cadherin, in 2002 by Rajgopal Govindarajan et al. to study connexin trafficking in androgen-independent human prostate cancer, and in 2003 by Jonathan Rios-Doria et al. (HECD-1) to study E-cadherin proteolytic cleavage in prostate and mammary epithelial cells.
|
TAKARA
|
|
In 2002, Miyuki Nishimura et al. used Takara rat monoclonal anti-E-cadherin antibody in immunocytochemistry to study the role of JEAP in exocrine cells, and Noriko Okazaki et al. used clone HECD-1 in immunohistochemistry to study the association of the expression of protocadherin LKC as a new candidate for a tumor suppressor of colon and liver cancers with contact inhibition of cell proliferation.
|
R & D SYSTEMS
Other Brands or Spellings: R&D SYSTEMS, R&D, RNDSYSTEMS, R & D SYSTEM |
|
In 2003 Josiane Sancacau et al. used R & D Systems anti-E-cadherin antibody (HECD-1, mIgG1) in blocking expriments to study the migratory-adhesive switch in Ewing's sarcoma cells triggered by matrix metalloproteinase-9 silencing, and in 2005, Thorsten Maretzky et al. used R & D Systems biotinylated anti-E-cadherin monoclonal antibody (clone 841487) in ELISA to study the regulation of E-cadherin shedding and beta-catenin translocation by ADAM10.
|
LAB VISION
Other Brands or Spellings: LABVISION, NEOMARKERS, NEOMARKER, LAB VISION/NEOMARKERS |
|
In 2005m Wei-Meng Zhao et al. used Lab Vision anti-Cdh1 antibody in immunocytochemistry to study the role of anillin during late cytokinesis, and in 2006 Sylvia Major et al. tested Lab Vision Cdh1 Ab-1 antibody in western blot by Abminer.
|
| ABCAM |
| In 2005 Anja Duursma et al. used Abcam Cdh1 antibody in western blot to investigate the regulation of Cdc6 protein stability by p53.
|
| TCS BIOLOGICALS |
| In 2002, D J Bloor et al. used TCS Biologicals E-cadherin mouse monoclonal antibody in immunohistochemistry to study its expression during human preimplantation embryo development.
|
COULTER IMMUNOTECH
Other Brands or Spellings: BECKMAN COULTER, IMMUNOTECH, IMMUNOTECH-COULTER, IMMUNOTECH INTERNATIONAL, COULTER-IMMUNOTECH |
| In 2003 Josiane Sancacau et al. used Coulter Immunotech monoclonal anti-E-cadherin antibody (67A4, mIgG1) in flow cytometry to study the migratory-adhesive switch in Ewing's sarcoma cells triggered by matrix metalloproteinase-9 silencing.
|
DAKO
Other Brands or Spellings: DAKOCYTOMATION, DAKO CYTOMATION, DAKO DIAGNOSTIC, DAKO CORP, DAKO CORPORATION, DAKO CORP., DAKO DIAGNOSTICS, DAKO A/S, DAKO DIAGNOSTIKA, DAKO LABORATORIES, DAKO-CYTOMATION, DAKO A/F, DAKOPATTS |
| In 2004, Viola A Heinzelmann-Schwarz et al. used DAKO anti-CDH1 antibody in immunohistochemistry to study its expression in metaplastic ovarian epithelium and ovarian cancer.
|
Articles Reviewed | | 1. T E Meigs et al. Interaction of Galpha 12 and Galpha 13 with the cytoplasmic domain of cadherin provides a mechanism for beta -catenin release. 2001 | | 2. A Suzuki et al. Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. 2001 | | 3. C Grötzinger et al. LI-cadherin: a marker of gastric metaplasia and neoplasia. 2001 | | 4. Miyuki Nishimura et al. JEAP, a novel component of tight junctions in exocrine cells. 2002 | | 5. Nathalie Jonca et al. Corneodesmosin, a component of epidermal corneocyte desmosomes, displays homophilic adhesive properties. 2002 | | 6. D J Bloor et al. Expression of cell adhesion molecules during human preimplantation embryo development. 2002 | | 7. Ya Chung Tian et al. Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. 2002 | | 8. Qi Chen et al. A novel mechanism for the regulation of amyloid precursor protein metabolism. 2002 | | 9. Noriko Okazaki et al. Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. 2002 | | 10. Maria Malminen et al. Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis. 2002 | | 11. Rajgopal Govindarajan et al. Impaired trafficking of connexins in androgen-independent human prostate cancer cell lines and its mitigation by alpha-catenin. 2002 | | 12. Jonathan Rios-Doria et al. The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. 2003 | | 13. Jose Piedra et al. p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction. 2003 | | 14. Victoria P Ramsauer et al. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, translocates ErbB2 to the apical surface in polarized epithelial cells. 2003 | | 15. Michael H Roh et al. The Crumbs3-Pals1 complex participates in the establishment of polarity in mammalian epithelial cells. 2003 | | 16. Carol Wadham et al. The protein tyrosine phosphatase Pez is a major phosphatase of adherens junctions and dephosphorylates beta-catenin. 2003 | | 17. Josiane Sancéau et al. Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells. 2003 | | 18. Philippe Marambaud et al. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. 2003 | | 19. Tsutomu Imai et al. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. 2003 | | 20. Etienne Morel et al. The cellular prion protein PrPc is expressed in human enterocytes in cell-cell junctional domains. 2004 | | 21. Martin Knöfler et al. Transcriptional regulation of the human chorionic gonadotropin beta gene during villous trophoblast differentiation. 2004 | | 22. Rachael Z Murray et al. The FAM deubiquitylating enzyme localizes to multiple points of protein trafficking in epithelia, where it associates with E-cadherin and beta-catenin. 2004 | | 23. Lillian Ouko et al. Wnt11 signaling promotes proliferation, transformation, and migration of IEC6 intestinal epithelial cells. 2004 | | 24. Viola A Heinzelmann-Schwarz et al. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. 2004 | | 25. Catherine Hogan et al. Rap1 regulates the formation of E-cadherin-based cell-cell contacts. 2004 | | 26. David M Bryant et al. Regulation of endocytosis, nuclear translocation, and signaling of fibroblast growth factor receptor 1 by E-cadherin. 2005 | | 27. Soichi Tsutsumi et al. Autocrine motility factor signaling enhances pancreatic cancer metastasis. 2004 | | 28. Nancy Gavert et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. 2005 | | 29. Takashi Hoshino et al. Regulation of E-cadherin endocytosis by nectin through afadin, Rap1, and p120ctn. 2005 | | 30. Agnieszka K Witkiewicz et al. Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis. 2005 | | 31. Thorsten Maretzky et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. 2005 | | 32. Olivera Stojadinovic et al. Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. 2005 | | 33. Wei-Meng Zhao et al. Anillin is a substrate of anaphase-promoting complex/cyclosome (APC/C) that controls spatial contractility of myosin during late cytokinesis. 2005 | | 34. Anja Duursma et al. p53-Dependent regulation of Cdc6 protein stability controls cellular proliferation. 2005 | | 35. Wen-Hui Lien et al. alphaE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway. 2006 | | 36. Sylvia Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 | | 37. A Persson et al. A human protein atlas based on antibody proteomics. 2006 |
|